In this episode, Medecision Advisory Board Chair Dr. Jan Berger gives some thought-provoking perspectives around what population health looks like during, as well as after, the COVID-19 pandemic, and what that may mean for the healthcare system.
Want to read more? Check out Dr. Berger’s blog post on how healthcare may change after COVID-19.
About The Author: Jan Berger, MD, MJ
Dr. Jan Berger is a tri-sector healthcare executive with proven results in private, public and government services over the last 30 years. In 2009, Jan founded Health Intelligence Partners, a global health care consultancy. She previously served as Senior Vice President, Chief Clinical Officer and Innovation Officer for CVS Health/Caremark, and is an assistant professor at Northwestern University School of Medicine and School of Communication. Jan serves on Medecision's Advisory Board, and sits on the boards of Cambia Health Solutions, GNS Healthcare, Tabula Rasa, Accent Care, UCB Pharmaceuticals and Voluntis Health Care.
More posts by Jan Berger, MD, MJ